Claudio Punzo

Co-Founder and CSO Trinetra Therapeutics

Dr. Punzo received his PhD from the University of Basel Switzerland working on Drosophila eye development in the laboratory of Dr. Walter J. Gehring. Thereafter he joined the laboratory of Dr. Constance L. Cepko in the Department of Genetics at Harvard Medical School for a post-doctoral fellowship on retinal degeneration. He is interested in retinal degeneration diseases that lead to blindness, and in particular retinal diseases that are associated with photoreceptor death such as retinitis pigmentosa, diabetic retinopathy and age related macular degeneration. The lab is currently developing various therapies for retinal diseases based on a siRNA chemistry that was identified in collaboration with the RNA Therapeutics Institute at the University of Massachusetts Chan Medical School.

Seminars

Friday 29th January 2027
Developing Tetravalent siRNAs for Efficient and Safe Silencing of Retinal Genes
1:00 pm
  • Exploring chemistries for retinal genes silencing
  • Understanding target cells for disease alterations
  • Establishing pre-clinical efficacies and safety in non-human primates

New Data

Claudio Punzo